Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,146 | 1,005 | 99.9% |
| Education | $12.87 | 2 | 0.1% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $4,010 | 234 | $0 (2024) |
| ABBVIE INC. | $3,716 | 180 | $0 (2024) |
| Janssen Biotech, Inc. | $1,689 | 80 | $0 (2024) |
| PFIZER INC. | $1,405 | 85 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,306 | 66 | $0 (2024) |
| Gilead Sciences, Inc. | $795.87 | 45 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $667.55 | 38 | $0 (2024) |
| Allergan, Inc. | $432.72 | 30 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $401.06 | 18 | $0 (2017) |
| Celgene Corporation | $391.24 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,164 | 137 | ABBVIE INC. ($633.32) |
| 2023 | $2,641 | 131 | AbbVie Inc. ($612.24) |
| 2022 | $2,974 | 153 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($874.16) |
| 2021 | $2,415 | 133 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($758.28) |
| 2020 | $1,791 | 106 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($601.29) |
| 2019 | $2,221 | 132 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($737.84) |
| 2018 | $2,007 | 108 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($546.83) |
| 2017 | $1,945 | 109 | Valeant Pharmaceuticals North America LLC ($401.06) |
All Payment Transactions
1,009 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: LIVER DISEASE | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Rare Disease | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Immunology | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $38.35 | General |
| Category: LIVER DISEASE | ||||||
| 11/27/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: Rare Disease | ||||||
| 11/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.28 | General |
| 11/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.18 | General |
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.79 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 573 | 612 | $223,989 | $64,035 |
| 2022 | 11 | 619 | 684 | $192,494 | $68,141 |
| 2021 | 12 | 857 | 941 | $253,014 | $94,117 |
| 2020 | 10 | 590 | 653 | $151,698 | $54,501 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 91 | 92 | $65,603 | $19,330 | 29.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 112 | 113 | $57,558 | $8,176 | 14.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 91 | 91 | $42,410 | $7,873 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 89 | $10,035 | $5,943 | 59.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 38 | $9,227 | $5,215 | 56.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $9,936 | $4,861 | 48.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 39 | $7,497 | $3,883 | 51.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 57 | $4,942 | $3,432 | 69.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $8,907 | $2,837 | 31.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $7,874 | $2,486 | 31.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 75 | 75 | $43,413 | $15,245 | 35.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 90 | 90 | $31,423 | $9,237 | 29.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 127 | 128 | $56,590 | $8,942 | 15.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 57 | $13,364 | $8,924 | 66.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 112 | $11,127 | $7,634 | 68.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 86 | $6,744 | $4,842 | 71.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $6,317 | $3,710 | 58.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 36 | $5,044 | $3,281 | 65.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $5,795 | $2,764 | 47.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $11,063 | $2,430 | 22.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 14 | $1,615 | $1,132 | 70.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 83 | 83 | $42,826 | $17,233 | 40.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 124 | 124 | $62,074 | $12,844 | 20.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 149 | 149 | $18,063 | $12,245 | 67.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 123 | 152 | $14,969 | $10,325 | 69.0% |
About Dr. Henry Beecher, M.D
Dr. Henry Beecher, M.D is a Gastroenterology healthcare provider based in Stamford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396949582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Beecher, M.D has received a total of $19,159 in payments from pharmaceutical and medical device companies, with $3,164 received in 2024. These payments were reported across 1,009 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($19,146).
As a Medicare-enrolled provider, Beecher has provided services to 2,639 Medicare beneficiaries, totaling 2,890 services with total Medicare billing of $280,793. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Stamford, CT
- Active Since 06/12/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396949582
Products in Payments
- XIFAXAN (Drug) $3,110
- XELJANZ (Drug) $1,389
- LINZESS (Drug) $912.48
- STELARA (Biological) $863.84
- RINVOQ (Biological) $752.03
- ENTYVIO (Biological) $733.19
- TRULANCE (Drug) $609.65
- REMICADE (Biological) $596.53
- HUMIRA (Biological) $559.85
- Linzess (Drug) $519.83
- CREON (Drug) $494.55
- XIFAXANIBSD (Drug) $429.78
- Creon (Drug) $392.38
- ZEPOSIA (Drug) $391.24
- Talicia (Drug) $368.26
- Entyvio (Biological) $363.74
- ZENPEP (Drug) $359.19
- VIBERZI (Drug) $328.06
- VOQUEZNA (Drug) $310.80
- SKYRIZI (Biological) $282.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Stamford
Dr. Robert Dettmer, Md, MD
Gastroenterology — Payments: $23,304
Stuart Waldstreicher, M.d, M.D
Gastroenterology — Payments: $5,605
Frederick Rozenshteyn, Md, MD
Gastroenterology — Payments: $796.15
Dr. Suma Magge, Md, MD
Gastroenterology — Payments: $744.60
Dr. Robert Plansky, Md, MD
Gastroenterology — Payments: $442.13
Jamil Alexis, Md, MD
Gastroenterology — Payments: $101.85